Chijioke Bennett

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 662 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial

Shabir A. Madhi, Dhayendre Moodley, Sherika Hanley et al. · The Lancet HIV · 2022 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson et al. · Scientific Reports · 2023 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · medRxiv · 2021 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

Chijioke Bennett, Wayne Woo, Mark Bloch et al. · The Lancet Infectious Diseases · 2024 · 19 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17